Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Contract Pharmaceutical Manufacturing Market 2018, Forecast to 2023

Publisher Name :
Date: 10-Jun-2018
No. of pages: 147

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Scope of the Report:

This report focuses on the Contract Pharmaceutical Manufacturing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.

The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.

In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.

North America and Europe is the industry's leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.

The worldwide market for Contract Pharmaceutical Manufacturing is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 96400 million US$ in 2023, from 68700 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- - Catalent

- - DPx

- - Lonza

- - Piramal Healthcare

- - Aenova

- - Jubilant

- - Famar

- - Boehringer Ingelheim

- - Fareva Holding

- - AbbVie

- - Nipro Corp

- - Vetter

- - Sopharma

- - DPT Laboratories

- - Recipharm

- - NextPharma

- - Dishman

- - Aesica

Market Segment by Regions, regional analysis covers

- - North America (United States, Canada and Mexico)

- - Europe (Germany, France, UK, Russia and Italy)

- - Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- - South America (Brazil, Argentina, Colombia etc.)

- - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- - API

- - FDF

Market Segment by Applications, can be divided into

- - Specialty/Midsize

- - Generics

- - Big Pharma

- - Other

There are 15 Chapters to deeply display the global Contract Pharmaceutical Manufacturing market.

Chapter 1, to describe Contract Pharmaceutical Manufacturing Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Contract Pharmaceutical Manufacturing, with sales, revenue, and price of Contract Pharmaceutical Manufacturing, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Contract Pharmaceutical Manufacturing, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Contract Pharmaceutical Manufacturing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Contract Pharmaceutical Manufacturing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Contract Pharmaceutical Manufacturing Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Contract Pharmaceutical Manufacturing Introduction
1.2 Market Analysis by Type
1.2.1 API
1.2.2 FDF
1.3 Market Analysis by Applications
1.3.1 Specialty/Midsize
1.3.2 Generics
1.3.3 Big Pharma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Catalent
2.1.1 Business Overview
2.1.1.1 Catalent Description
2.1.1.2 Catalent Headquarter, Main Business and Finance Overview
2.1.2 Catalent Contract Pharmaceutical Manufacturing Product Introduction
2.1.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.1.2.2 Contract Pharmaceutical Manufacturing Product Information
2.1.3 Catalent Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Catalent Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Catalent Contract Pharmaceutical Manufacturing Market Share in 2017
2.2 DPx
2.2.1 Business Overview
2.2.1.1 DPx Description
2.2.1.2 DPx Headquarter, Main Business and Finance Overview
2.2.2 DPx Contract Pharmaceutical Manufacturing Product Introduction
2.2.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.2.2.2 Contract Pharmaceutical Manufacturing Product Information
2.2.3 DPx Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 DPx Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global DPx Contract Pharmaceutical Manufacturing Market Share in 2017
2.3 Lonza
2.3.1 Business Overview
2.3.1.1 Lonza Description
2.3.1.2 Lonza Headquarter, Main Business and Finance Overview
2.3.2 Lonza Contract Pharmaceutical Manufacturing Product Introduction
2.3.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.3.2.2 Contract Pharmaceutical Manufacturing Product Information
2.3.3 Lonza Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Lonza Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Lonza Contract Pharmaceutical Manufacturing Market Share in 2017
2.4 Piramal Healthcare
2.4.1 Business Overview
2.4.1.1 Piramal Healthcare Description
2.4.1.2 Piramal Healthcare Headquarter, Main Business and Finance Overview
2.4.2 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Introduction
2.4.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.4.2.2 Contract Pharmaceutical Manufacturing Product Information
2.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Piramal Healthcare Contract Pharmaceutical Manufacturing Market Share in 2017
2.5 Aenova
2.5.1 Business Overview
2.5.1.1 Aenova Description
2.5.1.2 Aenova Headquarter, Main Business and Finance Overview
2.5.2 Aenova Contract Pharmaceutical Manufacturing Product Introduction
2.5.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.5.2.2 Contract Pharmaceutical Manufacturing Product Information
2.5.3 Aenova Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Aenova Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Aenova Contract Pharmaceutical Manufacturing Market Share in 2017
2.6 Jubilant
2.6.1 Business Overview
2.6.1.1 Jubilant Description
2.6.1.2 Jubilant Headquarter, Main Business and Finance Overview
2.6.2 Jubilant Contract Pharmaceutical Manufacturing Product Introduction
2.6.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.6.2.2 Contract Pharmaceutical Manufacturing Product Information
2.6.3 Jubilant Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Jubilant Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Jubilant Contract Pharmaceutical Manufacturing Market Share in 2017
2.7 Famar
2.7.1 Business Overview
2.7.1.1 Famar Description
2.7.1.2 Famar Headquarter, Main Business and Finance Overview
2.7.2 Famar Contract Pharmaceutical Manufacturing Product Introduction
2.7.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.7.2.2 Contract Pharmaceutical Manufacturing Product Information
2.7.3 Famar Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Famar Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Famar Contract Pharmaceutical Manufacturing Market Share in 2017
2.8 Boehringer Ingelheim
2.8.1 Business Overview
2.8.1.1 Boehringer Ingelheim Description
2.8.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.8.2 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Introduction
2.8.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.8.2.2 Contract Pharmaceutical Manufacturing Product Information
2.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Boehringer Ingelheim Contract Pharmaceutical Manufacturing Market Share in 2017
2.9 Fareva Holding
2.9.1 Business Overview
2.9.1.1 Fareva Holding Description
2.9.1.2 Fareva Holding Headquarter, Main Business and Finance Overview
2.9.2 Fareva Holding Contract Pharmaceutical Manufacturing Product Introduction
2.9.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.9.2.2 Contract Pharmaceutical Manufacturing Product Information
2.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Fareva Holding Contract Pharmaceutical Manufacturing Market Share in 2017
2.10 AbbVie
2.10.1 Business Overview
2.10.1.1 AbbVie Description
2.10.1.2 AbbVie Headquarter, Main Business and Finance Overview
2.10.2 AbbVie Contract Pharmaceutical Manufacturing Product Introduction
2.10.2.1 Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
2.10.2.2 Contract Pharmaceutical Manufacturing Product Information
2.10.3 AbbVie Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 AbbVie Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global AbbVie Contract Pharmaceutical Manufacturing Market Share in 2017
2.11 Nipro Corp
2.11.1 Business Overview
2.11.2 Nipro Corp Contract Pharmaceutical Manufacturing Product Introduction
2.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Vetter
2.12.1 Business Overview
2.12.2 Vetter Contract Pharmaceutical Manufacturing Product Introduction
2.12.3 Vetter Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sopharma
2.13.1 Business Overview
2.13.2 Sopharma Contract Pharmaceutical Manufacturing Product Introduction
2.13.3 Sopharma Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 DPT Laboratories
2.14.1 Business Overview
2.14.2 DPT Laboratories Contract Pharmaceutical Manufacturing Product Introduction
2.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Recipharm
2.15.1 Business Overview
2.15.2 Recipharm Contract Pharmaceutical Manufacturing Product Introduction
2.15.3 Recipharm Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 NextPharma
2.16.1 Business Overview
2.16.2 NextPharma Contract Pharmaceutical Manufacturing Product Introduction
2.16.3 NextPharma Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Dishman
2.17.1 Business Overview
2.17.2 Dishman Contract Pharmaceutical Manufacturing Product Introduction
2.17.3 Dishman Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Aesica
2.18.1 Business Overview
2.18.2 Aesica Contract Pharmaceutical Manufacturing Product Introduction
2.18.3 Aesica Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Contract Pharmaceutical Manufacturing Market Competition, by Manufacturer
3.1 Global Contract Pharmaceutical Manufacturing Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Contract Pharmaceutical Manufacturing Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Contract Pharmaceutical Manufacturing Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Contract Pharmaceutical Manufacturing Manufacturer Market Share in 2017
3.4.2 Top 5 Contract Pharmaceutical Manufacturing Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Contract Pharmaceutical Manufacturing Market Analysis by Regions
4.1 Global Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Regions
4.1.1 Global Contract Pharmaceutical Manufacturing Sales by Regions (2013-2018)
4.1.2 Global Contract Pharmaceutical Manufacturing Revenue by Regions (2013-2018)
4.2 North America Contract Pharmaceutical Manufacturing Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Contract Pharmaceutical Manufacturing Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Contract Pharmaceutical Manufacturing Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Contract Pharmaceutical Manufacturing Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Contract Pharmaceutical Manufacturing Sales, Revenue and Growth Rate (2013-2018)
5 North America Contract Pharmaceutical Manufacturing by Countries, Type, Application and Manufacturers
5.1 North America Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Countries
5.1.1 North America Contract Pharmaceutical Manufacturing Sales by Countries (2013-2018)
5.1.2 North America Contract Pharmaceutical Manufacturing Revenue by Countries (2013-2018)
5.1.3 United States Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
5.1.4 Canada Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
5.1.5 Mexico Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
5.2 North America Contract Pharmaceutical Manufacturing Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Contract Pharmaceutical Manufacturing Sales by Manufacturers (2016-2017)
5.2.2 North America Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2016-2017)
5.3 North America Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Contract Pharmaceutical Manufacturing Sales and Sales Share by Type (2013-2018)
5.3.2 North America Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Type (2013-2018)
5.4 North America Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Contract Pharmaceutical Manufacturing Sales and Sales Share by Application (2013-2018)
5.4.2 North America Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Application (2013-2018)
6 Europe Contract Pharmaceutical Manufacturing by Countries, Type, Application and Manufacturers
6.1 Europe Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Countries
6.1.1 Europe Contract Pharmaceutical Manufacturing Sales by Countries (2013-2018)
6.1.2 Europe Contract Pharmaceutical Manufacturing Revenue by Countries (2013-2018)
6.1.3 Germany Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
6.1.4 UK Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
6.1.5 France Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
6.1.6 Russia Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
6.1.7 Italy Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
6.2 Europe Contract Pharmaceutical Manufacturing Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Contract Pharmaceutical Manufacturing Sales by Manufacturers (2016-2017)
6.2.2 Europe Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2016-2017)
6.3 Europe Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Contract Pharmaceutical Manufacturing Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Contract Pharmaceutical Manufacturing Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Contract Pharmaceutical Manufacturing by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Contract Pharmaceutical Manufacturing Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Countries (2013-2018)
7.1.3 China Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
7.1.4 Japan Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
7.1.5 Korea Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
7.1.6 India Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Contract Pharmaceutical Manufacturing Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Contract Pharmaceutical Manufacturing Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Contract Pharmaceutical Manufacturing Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Contract Pharmaceutical Manufacturing Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Application (2013-2018)
8 South America Contract Pharmaceutical Manufacturing by Countries, Type, Application and Manufacturers
8.1 South America Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Countries
8.1.1 South America Contract Pharmaceutical Manufacturing Sales by Countries (2013-2018)
8.1.2 South America Contract Pharmaceutical Manufacturing Revenue by Countries (2013-2018)
8.1.3 Brazil Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
8.1.4 Argentina Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
8.1.5 Colombia Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
8.2 South America Contract Pharmaceutical Manufacturing Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Contract Pharmaceutical Manufacturing Sales by Manufacturers (2016-2017)
8.2.2 South America Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2016-2017)
8.3 South America Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Contract Pharmaceutical Manufacturing Sales and Sales Share by Type (2013-2018)
8.3.2 South America Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Type (2013-2018)
8.4 South America Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Contract Pharmaceutical Manufacturing Sales and Sales Share by Application (2013-2018)
8.4.2 South America Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Contract Pharmaceutical Manufacturing by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
9.1.4 UAE Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
9.1.5 Egypt Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
9.1.7 South Africa Contract Pharmaceutical Manufacturing Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Contract Pharmaceutical Manufacturing Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue and Revenue Share by Application (2013-2018)
10 Global Contract Pharmaceutical Manufacturing Market Segment by Type
10.1 Global Contract Pharmaceutical Manufacturing Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Contract Pharmaceutical Manufacturing Sales and Market Share by Type (2013-2018)
10.1.2 Global Contract Pharmaceutical Manufacturing Revenue and Market Share by Type (2013-2018)
10.2 API Sales Growth and Price
10.2.1 Global API Sales Growth (2013-2018)
10.2.2 Global API Price (2013-2018)
10.3 FDF Sales Growth and Price
10.3.1 Global FDF Sales Growth (2013-2018)
10.3.2 Global FDF Price (2013-2018)
11 Global Contract Pharmaceutical Manufacturing Market Segment by Application
11.1 Global Contract Pharmaceutical Manufacturing Sales Market Share by Application (2013-2018)
11.2 Specialty/Midsize Sales Growth (2013-2018)
11.3 Generics Sales Growth (2013-2018)
11.4 Big Pharma Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Contract Pharmaceutical Manufacturing Market Forecast (2018-2023)
12.1 Global Contract Pharmaceutical Manufacturing Sales, Revenue and Growth Rate (2018-2023)
12.2 Contract Pharmaceutical Manufacturing Market Forecast by Regions (2018-2023)
12.2.1 North America Contract Pharmaceutical Manufacturing Market Forecast (2018-2023)
12.2.2 Europe Contract Pharmaceutical Manufacturing Market Forecast (2018-2023)
12.2.3 Asia-Pacific Contract Pharmaceutical Manufacturing Market Forecast (2018-2023)
12.2.4 South America Contract Pharmaceutical Manufacturing Market Forecast (2018-2023)
12.2.5 Middle East and Africa Contract Pharmaceutical Manufacturing Market Forecast (2018-2023)
12.3 Contract Pharmaceutical Manufacturing Market Forecast by Type (2018-2023)
12.3.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Type (2018-2023)
12.3.2 Global Contract Pharmaceutical Manufacturing Market Share Forecast by Type (2018-2023)
12.4 Contract Pharmaceutical Manufacturing Market Forecast by Application (2018-2023)
12.4.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Application (2018-2023)
12.4.2 Global Contract Pharmaceutical Manufacturing Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Contract Pharmaceutical Manufacturing Picture
Table Product Specifications of Contract Pharmaceutical Manufacturing
Figure Global Contract Pharmaceutical Manufacturing CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Contract Pharmaceutical Manufacturing CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Contract Pharmaceutical Manufacturing by Types in 2017
Figure API Picture
Table Major Manufacturers of API
Figure FDF Picture
Table Major Manufacturers of FDF
Figure Contract Pharmaceutical Manufacturing Sales Market Share by Applications in 2017
Figure Specialty/Midsize Picture
Figure Generics Picture
Figure Big Pharma Picture
Figure Other Picture
Figure United States Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure France Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure UK Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure China Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure India Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Contract Pharmaceutical Manufacturing Revenue (Value) and Growth Rate (2013-2023)
Table Catalent Headquarter, Established, Main Business and Finance Overview (2017)
Table Catalent Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table Catalent Contract Pharmaceutical Manufacturing Product
Table Catalent Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Catalent Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global Catalent Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table DPx Headquarter, Established, Main Business and Finance Overview (2017)
Table DPx Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table DPx Contract Pharmaceutical Manufacturing Product
Table DPx Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global DPx Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global DPx Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table Lonza Headquarter, Established, Main Business and Finance Overview (2017)
Table Lonza Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table Lonza Contract Pharmaceutical Manufacturing Product
Table Lonza Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lonza Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global Lonza Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table Piramal Healthcare Headquarter, Established, Main Business and Finance Overview (2017)
Table Piramal Healthcare Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table Piramal Healthcare Contract Pharmaceutical Manufacturing Product
Table Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Piramal Healthcare Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table Aenova Headquarter, Established, Main Business and Finance Overview (2017)
Table Aenova Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table Aenova Contract Pharmaceutical Manufacturing Product
Table Aenova Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Aenova Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global Aenova Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table Jubilant Headquarter, Established, Main Business and Finance Overview (2017)
Table Jubilant Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table Jubilant Contract Pharmaceutical Manufacturing Product
Table Jubilant Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Jubilant Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global Jubilant Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table Famar Headquarter, Established, Main Business and Finance Overview (2017)
Table Famar Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table Famar Contract Pharmaceutical Manufacturing Product
Table Famar Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Famar Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global Famar Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product
Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales Market Share in 2017
Figure Global Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue Market Share in 2017
Table Fareva Holding Headquarter, Established, Main Business and Finance Overview (2017)
Table Fareva Holding Contract Pharmaceutical Manufacturing Production Bases, Sales Regions and Major Competito
  • 2018-2023 Global PEGylated Proteins Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PEGylated Proteins market for 2018-2023. PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there a......
  • 2018 Top 5 PEGylated Proteins Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturer......
  • 2018-2023 Global Erythropoietin Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Erythropoietin market for 2018-2023. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adult......
  • 2018 Top 5 Erythropoietin Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, t......
  • Global Enzymatic Debridement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Enzymatic Debridement Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, By End User, Companies
    Published: 14-Jun-2018        Price: US 1990 Onwards        Pages: 355
    Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from th......
  • Global Celery Seed Extract Solid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 135
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Celery Seed Extract Solid Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs